ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Phase 3 Recruiting 15 enrolled Ono Pharmaceutical Co., Ltd.

NaSingle-groupOpen-labelTreatment

Summary

To investigate the efficacy and safety of ONO-2017 in combination with antiepileptics in Japanese epileptic patients with generalized tonic-clonic seizures.

Timeline

Start: 2022-07-12
Primary completion: 2027-01-31
Completion: 2027-01-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cenobamate	Small molecule	—	Oral

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Summary

Timeline

Drugs

Indications